<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01890707</url>
  </required_header>
  <id_info>
    <org_study_id>STU00062431</org_study_id>
    <nct_id>NCT01890707</nct_id>
  </id_info>
  <brief_title>Intravenous Sedation Versus General Anesthesia in Patients Undergoing Minor Gynecologic Surgery</brief_title>
  <official_title>A Comparison of the Effect of Intravenous Sedation Versus General Anesthesia in Patients Undergoing Minor Gynecologic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of deep sedation may improve the quality of recovery of patients undergoing minor
      gynecologic procedures. These patients may also have shorter hospital stays and potentially
      lower healthcare costs. Additionally, the use of deep sedation for second trimester pregnancy
      termination may be associated with less bleeding, a smaller decrease in perioperative
      hemoglobin and better quality of recovery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Once consent for the study has been obtained subjects will be randomly allocated into 2
      groups, using a computer generated table of random numbers. Anesthetic management will be
      standardized (Appendix 1, 2). Group A (study group) will receive deep sedation . Group B
      (control group) will receive general anesthesia. Subjects will be instructed preoperatively,
      on the proper use of the verbal rating scale (VRS) for pain and nausea scores. All patients
      routinely have a blood count checked preoperatively and based on the results are either
      screened for cross matched for potential transfusion. All subjects will complete the POMS
      questionnaire preoperatively.

      Gestational size will be determined by the surgeon preoperatively using the most recent
      ultrasound measurements.

      Participants will undergo a standard pre-operative evaluation, laboratory testing and
      laminaria insertion one day prior to surgery in the Family Planning and Contraception Clinic.
      All subjects will receive a prescription for ibuprofen 600mg and hydrocodone/acetaminophen
      5/325mg with standardized instructions to take the last oral dose no later than six hours
      before the operative time. The last dose medication and time of administration will be
      recorded.

      Intraoperative management:

      A standardized intraoperative anesthetic protocol will be utilized by the anesthesia
      personnel (Appendix #1, 2).Clinical management of excessive intraoperative bleeding will be
      at the discretion of the anesthesiologist.

      Intraoperative red blood cell loss will be estimated based on hematacrit of the contents of
      suction canister. The surgical field will be draped carefully so that all blood lost will
      either be collected in the suction canister or the pocket of the vaginal drape, so that it
      can also be suction into the canister prior to obtaining the laboratory sample. Every attempt
      will be made by the surgeons to keep all unaccounted blood loss to gloves, instruments,
      drapes, surgery table and OR floor, to a minimum. The suction tubing will be rinsed with50
      mls of saline at the end of the procedure.

      All participants will receive a standard paracervical block of 20ml. of 1% lidocaine with 5
      units of vasopressin. Further uterotonics or surgical intervention for excessive bleeding
      will be at the discretion of the surgeon and documented in study data sheets.

      Postoperative management:

      Immediately postoperatively the surgeon of record will be asked to rate the quality of the
      anesthesia provided to the patient. He / she will complete a Surgeon Satisfaction with
      Intraoperative Sedation survey. (Appendix # 3)

      In the recovery room, VRS for pain will be assessed upon admission and at 30 minute intervals
      thereafter. Analgesics will be administered according to the severity of the pain. Subjects
      will receive oral analgesics unless they are unable to take oral analgesics, in which case IV
      hydromorphone will be administered.

      Vomiting and retching episodes will be assessed at 30 minute intervals using a VRS, and
      patients with scores greater than 4 or those who request antiemetic treatment will be treated
      with ondansetron 4mg IV.

      Postoperative blood loss will be measured by weighing the patient dressings with a precision
      computerized scale system prior to discarding them. Prior to the subjects discharge from the
      facility, a drop of venous blood will be obtained from the existing intravenous catheter, for
      measurement hemoglobin. Hemoglobin determination of less than 8 gms/dL, will be verified with
      the hospital laboratory. Management decisions will be made in conjunction with the surgeon,
      based on the subject's clinical status.

      Recovery from anesthesia and return of psychomotor ability will be assessed using the
      Modified Post Anesthesia Discharge Scoring System (MPADSS, see Appendix #6). A score of &gt; 9
      will indicate discharge readiness. Discharge readiness requires that a patient be awake and
      alert with stable vital signs, able to ambulate without assistance, and free of side effects.

      Times from end of surgery to oral intake and readiness for discharge, and all adverse events
      and medications administered will be recorded. Subjects will be contacted by telephone 24
      hours after surgery to obtain post-discharge data, including a QoR-40 assessment and a
      Pittsburgh Sleep Quality Index survey (PSQI).

      Discharge analgesia and antiemetic medications will be standardized.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Change in procedure.
  </why_stopped>
  <start_date type="Actual">October 19, 2012</start_date>
  <completion_date type="Actual">April 17, 2014</completion_date>
  <primary_completion_date type="Actual">April 15, 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of Recovery - 40 Scores</measure>
    <time_frame>24 hours</time_frame>
    <description>The patients self reported quality of recovery - 40 scores as completed 24 hours after the surgical procedure.
40 questions regarding the recovery of patients on a 1 poor-5 excellent scale. Total score on scale 40 (poor recovery)-200 (excellent recovery)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Surgery</condition>
  <condition>Anesthesia</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Deep Sedation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Deep sedation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>General Anesthesia</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Administration of general anesthesia. Propofol given IV, succinylcholine and rocuronium given IV and Sevoflurane via the endotracheal tube.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>General Anesthesia</intervention_name>
    <description>Administer: Fentanyl:1mcg/kg prior to induction, additional doses to maintain blood pressure and heart rate within 20% of preoperative values, Propofol:2mg/kg,succinylcholine, 0.5mg/kg,to be followed with Rocuronium if necessary,bolus: 0.4mg/kg, Sevoflurane and oxygen to be titrated to maintain BIS value of 40-60.</description>
    <arm_group_label>General Anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Deep Sedation</intervention_name>
    <description>IV administration of Propofol,initial rate 100ug/kg/min, titrated to maintain BIS 65-75,Fentanyl,Ketamine,1mcg/kg,0.5mg/kg,additional 10mg increments for analgesia/movement.</description>
    <arm_group_label>Deep Sedation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female patients undergoing second trimester abortions:

          -  Pregnancy: 12-24 weeks gestational size

          -  ASA PS I and II

          -  No history of diabetes mellitus, GERD or sleep apnea

          -  Age: &gt; 18 years of age

          -  Fluent in English

        Exclusion Criteria:

          -  ASA PSIII, Emergency surgery

          -  Pregnancy: &gt; 24 weeks gestational size

          -  Age: &lt; 18 years of age

          -  Diabetes mellitus

          -  Gastroesophageal reflux disease

          -  Hiatal hernia

          -  Obstructive sleep apnea

          -  Coagulopathy

          -  Chronic pain syndromes

          -  Chronic opioid dependency

          -  Alcohol or illicit drug abuse

          -  BMI: &gt; 35Kg/m2

          -  Allergy to study protocol drugs

        Drop out criteria:

          -  Subjects withdrawal of consent.

          -  Subjects who experience massive bleeding intraoperatively, will be excluded from the
             final data analysis
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shireen Ahmad, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Prentice Womens' Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Sá Rêgo MM, White PF. What is new in monitored anesthesia care? Curr Opin Anaesthesiol. 1998 Dec;11(6):601-6.</citation>
    <PMID>17013278</PMID>
  </reference>
  <reference>
    <citation>Sá Rêgo MM, Watcha MF, White PF. The changing role of monitored anesthesia care in the ambulatory setting. Anesth Analg. 1997 Nov;85(5):1020-36. Review.</citation>
    <PMID>9356094</PMID>
  </reference>
  <reference>
    <citation>Song D, Greilich NB, White PF, Watcha MF, Tongier WK. Recovery profiles and costs of anesthesia for outpatient unilateral inguinal herniorrhaphy. Anesth Analg. 2000 Oct;91(4):876-81.</citation>
    <PMID>11004041</PMID>
  </reference>
  <reference>
    <citation>Snyder SK, Roberson CR, Cummings CC, Rajab MH. Local Anesthesia With Monitored Anesthesia Care vs General Anesthesia in Thyroidectomy: A Randomized Study. Arch Surg. 2006 Feb;141(2):167-73.</citation>
    <PMID>16490894</PMID>
  </reference>
  <reference>
    <citation>Scarborough DA, Herron JB, Khan A, Bisaccia E. Experience with more than 5,000 cases in which monitored anesthesia care was used for liposuction surgery. Aesthetic Plast Surg. 2003 Nov-Dec;27(6):474-80. Epub 2004 Mar 4. Review.</citation>
    <PMID>14994165</PMID>
  </reference>
  <reference>
    <citation>Eldor L, Weissman A, Fodor L, Carmi N, Ullmann Y. Breast augmentation under general anesthesia versus monitored anesthesia care: a retrospective comparative study. Ann Plast Surg. 2008 Sep;61(3):243-6. doi: 10.1097/SAP.0b013e31815bfe98.</citation>
    <PMID>18724120</PMID>
  </reference>
  <reference>
    <citation>EDWARDS G, MORTON HJ, PASK EA, WYLIE WD. Deaths associated with anaesthesia; a report on 1,000 cases. Anaesthesia. 1956 Jul;11(3):194-220.</citation>
    <PMID>13340197</PMID>
  </reference>
  <reference>
    <citation>Warner MA, Shields SE, Chute CG. Major morbidity and mortality within 1 month of ambulatory surgery and anesthesia. JAMA. 1993 Sep 22-29;270(12):1437-41.</citation>
    <PMID>8371443</PMID>
  </reference>
  <reference>
    <citation>Aldrete JA, Kroulik D. A postanesthetic recovery score. Anesth Analg. 1970 Nov-Dec;49(6):924-34.</citation>
    <PMID>5534693</PMID>
  </reference>
  <reference>
    <citation>White PF. Criteria for fast-tracking outpatients after ambulatory surgery. J Clin Anesth. 1999 Feb;11(1):78-9.</citation>
    <PMID>10396724</PMID>
  </reference>
  <reference>
    <citation>Chung F, Chan VW, Ong D. A post-anesthetic discharge scoring system for home readiness after ambulatory surgery. J Clin Anesth. 1995 Sep;7(6):500-6.</citation>
    <PMID>8534468</PMID>
  </reference>
  <reference>
    <citation>Wong J, Tong D, De Silva Y, Abrishami A, Chung F. Development of the functional recovery index for ambulatory surgery and anesthesia. Anesthesiology. 2009 Mar;110(3):596-602. doi: 10.1097/ALN.0b013e318197a16d.</citation>
    <PMID>19212260</PMID>
  </reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>June 1, 2012</study_first_submitted>
  <study_first_submitted_qc>July 1, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2013</study_first_posted>
  <results_first_submitted>September 12, 2017</results_first_submitted>
  <results_first_submitted_qc>December 11, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">January 2, 2020</results_first_posted>
  <last_update_submitted>December 11, 2019</last_update_submitted>
  <last_update_submitted_qc>December 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Shireen Ahmad</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Gynecology</keyword>
  <keyword>Pain</keyword>
  <keyword>Anesthesia</keyword>
  <keyword>Quality of Recovery 40</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects will be recruited up to 14 days prior to surgery, by either the anesthesiology or the gynecology investigators. A preoperative anesthetic assessment will be completed. Once consent for the study has been obtained subjects will be randomly allocated into 2 groups, using a computer generated table of random numbers.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Deep Sedation</title>
          <description>Deep sedation
Deep Sedation: IV administration of Propofol,initial rate 100ug/kg/min, titrated to maintain BIS 65-75,Fentanyl,Ketamine,1mcg/kg,0.5mg/kg,additional 10mg increments for analgesia/movement.</description>
        </group>
        <group group_id="P2">
          <title>General Anesthesia</title>
          <description>Administration of general anesthesia. Propofol given IV, succinylcholine and rocuronium given IV and Sevoflurane via the endotracheal tube.
General Anesthesia: Administer: Fentanyl:1mcg/kg prior to induction, additional doses to maintain blood pressure and heart rate within 20% of preoperative values, Propofol:2mg/kg,succinylcholine, 0.5mg/kg,to be followed with Rocuronium if necessary,bolus: 0.4mg/kg, Sevoflurane and oxygen to be titrated to maintain BIS value of 40-60.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Deep Sedation</title>
          <description>Deep sedation
Deep Sedation: IV administration of Propofol,initial rate 100ug/kg/min, titrated to maintain BIS 65-75,Fentanyl,Ketamine,1mcg/kg,0.5mg/kg,additional 10mg increments for analgesia/movement.</description>
        </group>
        <group group_id="B2">
          <title>General Anesthesia</title>
          <description>Administration of general anesthesia. Propofol given IV, succinylcholine and rocuronium given IV and Sevoflurane via the endotracheal tube.
General Anesthesia: Administer: Fentanyl:1mcg/kg prior to induction, additional doses to maintain blood pressure and heart rate within 20% of preoperative values, Propofol:2mg/kg,succinylcholine, 0.5mg/kg,to be followed with Rocuronium if necessary,bolus: 0.4mg/kg, Sevoflurane and oxygen to be titrated to maintain BIS value of 40-60.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="7"/>
            <count group_id="B3" value="17"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="7"/>
                    <count group_id="B3" value="17"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="07"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="7"/>
                    <count group_id="B3" value="17"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34.3" spread="3.46"/>
                    <measurement group_id="B2" value="35" spread="7.3"/>
                    <measurement group_id="B3" value="34.5" spread="5.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="7"/>
                    <count group_id="B3" value="17"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="7"/>
                    <count group_id="B3" value="17"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height Inches</title>
          <units>Inches</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="7"/>
                    <count group_id="B3" value="17"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67.1" spread="2.3"/>
                    <measurement group_id="B2" value="64" spread="1.85"/>
                    <measurement group_id="B3" value="65.8" spread="2.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Kilogram Weight</title>
          <units>Kilogram Weight</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="7"/>
                    <count group_id="B3" value="17"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="73.9" spread="13.8"/>
                    <measurement group_id="B2" value="64.6" spread="6.3"/>
                    <measurement group_id="B3" value="70.07" spread="12.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gestational Age</title>
          <units>Weeks</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="7"/>
                    <count group_id="B3" value="17"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19.17" spread="2.13"/>
                    <measurement group_id="B2" value="19.85" spread="2.58"/>
                    <measurement group_id="B3" value="19.45" spread="2.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Quality of Recovery - 40 Scores</title>
        <description>The patients self reported quality of recovery - 40 scores as completed 24 hours after the surgical procedure.
40 questions regarding the recovery of patients on a 1 poor-5 excellent scale. Total score on scale 40 (poor recovery)-200 (excellent recovery)</description>
        <time_frame>24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Deep Sedation</title>
            <description>Deep sedation
Deep Sedation: IV administration of Propofol,initial rate 100ug/kg/min, titrated to maintain BIS 65-75,Fentanyl,Ketamine,1mcg/kg,0.5mg/kg,additional 10mg increments for analgesia/movement.</description>
          </group>
          <group group_id="O2">
            <title>General Anesthesia</title>
            <description>Administration of general anesthesia. Propofol given IV, succinylcholine and rocuronium given IV and Sevoflurane via the endotracheal tube.
General Anesthesia: Administer: Fentanyl:1mcg/kg prior to induction, additional doses to maintain blood pressure and heart rate within 20% of preoperative values, Propofol:2mg/kg,succinylcholine, 0.5mg/kg,to be followed with Rocuronium if necessary,bolus: 0.4mg/kg, Sevoflurane and oxygen to be titrated to maintain BIS value of 40-60.</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Recovery - 40 Scores</title>
          <description>The patients self reported quality of recovery - 40 scores as completed 24 hours after the surgical procedure.
40 questions regarding the recovery of patients on a 1 poor-5 excellent scale. Total score on scale 40 (poor recovery)-200 (excellent recovery)</description>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="183.4" spread="13.86"/>
                    <measurement group_id="O2" value="177.2" spread="16.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>To the time the subject was discharged from the hospital.</time_frame>
      <desc>Hypertension systolic blood pressure greater than 160 mmHg.</desc>
      <group_list>
        <group group_id="E1">
          <title>Deep Sedation</title>
          <description>Deep sedation
Deep Sedation: IV administration of Propofol,initial rate 100ug/kg/min, titrated to maintain BIS 65-75,Fentanyl,Ketamine,1mcg/kg,0.5mg/kg,additional 10mg increments for analgesia/movement.</description>
        </group>
        <group group_id="E2">
          <title>General Anesthesia</title>
          <description>Administration of general anesthesia. Propofol given IV, succinylcholine and rocuronium given IV and Sevoflurane via the endotracheal tube.
General Anesthesia: Administer: Fentanyl:1mcg/kg prior to induction, additional doses to maintain blood pressure and heart rate within 20% of preoperative values, Propofol:2mg/kg,succinylcholine, 0.5mg/kg,to be followed with Rocuronium if necessary,bolus: 0.4mg/kg, Sevoflurane and oxygen to be titrated to maintain BIS value of 40-60.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Shireen Ahmad MD</name_or_title>
      <organization>Northwestern University</organization>
      <phone>312-472-3585</phone>
      <email>sahmad@northwestern.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

